Connect with us at Gene Therapy Development 2024

Leverage our 50 years of experience and integrated CDMO solutions for your advanced therapy programs

At Rentschler Biopharma, reliability you can trust is more than a promise—it's our commitment. As a global leader in CDMO services for biopharmaceuticals, including advanced therapies, we take pride in our contributions to nearly 25% of FDA-approved biopharmaceuticals in 2023. 

Schedule a meeting

We are looking forward to seeing you at this year's Gene Therapy Development Conference


Stand: 1

Date: June 13-14, 2024

Location: ILEC Conference Center, London, UK

Event Website: link

Discover our Service Portfolio

We offer integrated CDMO solutions for viral vector process and analytical development, cGMP manufacturing and QC, complemented by our client program management and regulatory affairs services. 

Rentschler Biopharma CDMO bioprocess development for groundbreaking CGT
Process Development

Discover more

Rentschler Biopharma CDMO viral vector production at any scale
cGMP manufacturing


Discover more

Rentschler Biopharma CDMO industry-leading consulting services for regulatory success
Expert Regulatory Consultation

Discover more

Rentschler Biopharma CDMO cGMP manufacturing at state-of-the-art facilities
Client Program Management

Discover more

Get in Touch with our Business Development Team

Are you interested in learning more? We look forward to hearing from you!

Robert Panting
General Manager, ATMP

*Erforderliche Felder